Effect of Tivantinib on the QTC Interval in Cancer Subjects

This study has been completed.
Sponsor:
Collaborator:
Medpace, Inc.
Information provided by (Responsible Party):
Daiichi Sankyo Inc.
ClinicalTrials.gov Identifier:
NCT01699061
First received: October 1, 2012
Last updated: September 30, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)